H-CYTE (HCYTD) Stock Price, News & Analysis

Company Overview

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Key Stats

• Today's Range: $2.02 to $2.77
• 50-Day Range: $2.02 to $2.02
• 52-Week Range: $2.02 to $77.00
• Volume: 400 shs
• Average Volume: 103 shs
• Market Capitalization: $521.16 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HCYTD Stock Analysis - Frequently Asked Questions

How have HCYTD shares performed this year?

H-CYTE's stock was trading at $2.02 at the beginning of the year. Since then, HCYTD shares have increased by 0.0% and is now trading at $2.02.
View the best growth stocks for 2025 here.

How do I buy shares of H-CYTE?

Shares of HCYTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 6/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:HCYTD
• CIK: 1591165
• Web: www.hcyte.com
• Phone: (844) 633-6839
• Fax: N/A
• Employees: 8
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$4.80 million
• Net Margins: -450.40%
• Pretax Margin: -450.40%
• Return on Equity: N/A
• Return on Assets: -777.68%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.12
• Quick Ratio: 0.12

Sales & Book Value

• Annual Sales: $1.61 million
• Price / Sales: 0.32
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($31.45) per share
• Price / Book: -0.06

Miscellaneous

• Outstanding Shares: 258,000
• Free Float: 244,000
• Market Cap: $521.16 thousand
• Optionable: Not Optionable
• Beta: 1.12